glp 1 receptor agonists are contraindicated in contraindications to Dr Medica || Clinical MCQ π βMost important contraindication of GLP-1 agonists? A. Asthma B. Medullary thyroid carcinoma C. Hypertension D. Diabetes type 2 β οΈ Educational content only β not medical advice. # Clinical Recommendations to Manage Gastrointestinal
Description
Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes

Semaglutide Phase 2 Trial: 59% NASH resolution at 0.4 mg/day Building upon the foundation established by the LEAN trial, researchers subsequently conducted a larger phase 2 trial evaluating semaglutides efficacy in NASH patients

This dual action likely explains why tirzepatide often produces greater average weight loss in clinical studies, he says

Patients using GLP-1 therapies for weight loss often have different expectations and motivations compared to those using them for diabetes
In clinical trials, semaglutide at 0.4 mg daily led to an average 13% reduction in body weight
